For the secondary outcome of death, 15.5% of those who received erythropoietin died compared with 12.2% of the placebo group ...

The only treatment supported by randomized clinical trials (RCT) is therapeutic hypothermia for infants at least 36 weeks' gestational age, study authors wrote. "Many clinicians have been ...

Though long-term study results are beginning to be published and appear promising, there is still limited information regarding the childhood outcomes of encephalopathic infants treated with TH.